Trent Hummel

Summary

Affiliation: Cincinnati Children's Hospital Medical Center
Country: USA

Publications

  1. doi request reprint A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium study
    Trent R Hummel
    Division of Oncology, Cincinnati Children s Hospital Medical Center, Cancer and Blood Diseases Institute, Cincinnati, Ohio 45229, USA
    Pediatr Blood Cancer 60:1452-7. 2013
  2. doi request reprint Pharmacotherapeutic management of pediatric gliomas : current and upcoming strategies
    Trent R Hummel
    Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children s Hospital Medical Center, Cincinnati, OH 45229, USA
    Paediatr Drugs 15:29-42. 2013
  3. doi request reprint Clinical heterogeneity of desmoplastic infantile ganglioglioma: a case series and literature review
    Trent R Hummel
    Cancer and Blood Diseases Institute, Division of Oncology, Cincinnati Children s Hospital Medical Center, Cincinnati OH 45229 3039, USA
    J Pediatr Hematol Oncol 34:e232-6. 2012
  4. doi request reprint Response of NF1-related plexiform neurofibroma to high-dose carboplatin
    Trent Hummel
    Division of Hematology Oncology, Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio 45229, USA
    Pediatr Blood Cancer 56:488-90. 2011
  5. ncbi request reprint Response of NF1-related plexiform neurofibroma to High-Dose Carboplatin
    Trent Hummel
    Division of Hematology Oncology, Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio
    Pediatr Blood Cancer 56:488-90. 2011

Detail Information

Publications5

  1. doi request reprint A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium study
    Trent R Hummel
    Division of Oncology, Cincinnati Children s Hospital Medical Center, Cancer and Blood Diseases Institute, Cincinnati, Ohio 45229, USA
    Pediatr Blood Cancer 60:1452-7. 2013
    ....
  2. doi request reprint Pharmacotherapeutic management of pediatric gliomas : current and upcoming strategies
    Trent R Hummel
    Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children s Hospital Medical Center, Cincinnati, OH 45229, USA
    Paediatr Drugs 15:29-42. 2013
    ..Further research is required to understand the biology of pediatric gliomas as well as the use of molecularly targeted agents, especially in patients with surgically unresectable tumors...
  3. doi request reprint Clinical heterogeneity of desmoplastic infantile ganglioglioma: a case series and literature review
    Trent R Hummel
    Cancer and Blood Diseases Institute, Division of Oncology, Cincinnati Children s Hospital Medical Center, Cincinnati OH 45229 3039, USA
    J Pediatr Hematol Oncol 34:e232-6. 2012
    ..Such adverse outcomes, combined with the recognition that DIG represents a heterogeneous disease, underscore the need for an expanded biological and molecular investigation...
  4. doi request reprint Response of NF1-related plexiform neurofibroma to high-dose carboplatin
    Trent Hummel
    Division of Hematology Oncology, Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio 45229, USA
    Pediatr Blood Cancer 56:488-90. 2011
    ..Here, we present a case in which we describe the use of high-dose carboplatin to treat the patient's testicular seminoma which resulted in the decrease in size of a PN in a patient with NF1...
  5. ncbi request reprint Response of NF1-related plexiform neurofibroma to High-Dose Carboplatin
    Trent Hummel
    Division of Hematology Oncology, Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio
    Pediatr Blood Cancer 56:488-90. 2011
    ..Pediatr Blood Cancer 2011;56:488-490. © 2010 Wiley-Liss, Inc...